Nuvalent, Inc. (NUVL)
105.09
-2.78
(-2.58%)
USD |
NASDAQ |
Dec 09, 16:00
104.89
-0.20
(-0.19%)
After-Hours: 20:00
Nuvalent EPS Diluted (Quarterly): -1.697 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Pfizer Inc. | 0.6197 |
| Xencor, Inc. | -0.081 |
| Glaukos Corp. | -0.2828 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.44M |
| Total Expenses (Quarterly) | 122.44M |
| Enterprise Value | 6.698B |
| Earnings Yield | -5.06% |
| Normalized Earnings Yield | -4.794 |